Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01190865 · ClinicalTrials.gov registry record · Phase 1
Study of Survival Duration for Donor Skin Cells in Skin Biopsy Wounds
A Phase 1 study, sponsored by Healthpoint.
- Completed
- Registry status
- Phase 1
- Development phase
- 28
- Enrollment target
NCT01190865 is a Phase 1 study that has completed, run by Healthpoint. The registered enrollment target is 28 participants.
The verdict
NCT01190865, a Phase 1 study, has completed, sponsored by Healthpoint.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 28 participants
- Enrollment target
Study Summary
The goal for this study is to examine the persistence of growth arrested,allogeneic,male-donor keratinocytes and fibroblasts when applied as product HP802-247 to the surface of acute excisional wounds in health female volunteers, as measured using Y-STR for detection of Y-chromosome.
Interventions
- BIOLOGICAL HP802-247
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2010-09 |
| Est. Completion | 2010-12 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01190865
The ClinicalTrials.gov registry entry for NCT01190865 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Healthpoint, which has 25 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which HP802-247 is the first listed.
NCT01190865 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01190865 about?
NCT01190865 is a clinical study titled "Study of Survival Duration for Donor Skin Cells in Skin Biopsy Wounds". The goal for this study is to examine the persistence of growth arrested,allogeneic,male-donor keratinocytes and fibroblasts when applied as product HP802-247 to the surface of acute excisional wounds in health female volunteers, as measured using Y-STR for detection of Y-chromosome.
What is the current status of trial NCT01190865?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 28 participants. The study started on 2010-09. Estimated completion is 2010-12.
What interventions are being tested in trial NCT01190865?
The interventions under investigation include: HP802-247 (BIOLOGICAL).
Who is sponsoring clinical trial NCT01190865?
This trial is sponsored by Healthpoint, which has 25 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.